Finally, a transgenic light chain amyloidosis mouse model.

Jeffery W Kelly1

  • 1The Scripps Research Institute.

Blood
|December 17, 2011
PubMed
Summary

Researchers developed the first transgenic mouse model for light chain amyloidosis. This new model effectively aids in evaluating potential pharmaceutical treatments for the condition.